Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating whether to stop or continue urate-lowering therapy in gout patients based on ultrasound features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • urate-lowering therapy

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gout Chronic | Phase 2 | Status: NOT_YET_RECRUITING